Show Equivalence of the Modified BreathID Compared to Currently Approved BreathID in H.Pylori Detection
14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication
Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy
|4||Not yet recruiting||
10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection
† Study has passed its completion date and status has not been verified in more than two years.